Pharmacology Ivacaftor was approved by FDA in 2018 for A Cystic fibrosis B Migraine C Hypeension D Glycogen storage disorders 💡 Explanation Ivacaftor was approved by FDA in 2018 for ✓ Correct Answer: A. Cystic fibrosis